Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
- An X-linked glycolipid storage disease caused by mutation in GLA gene causing a deficiency of the lysosomal enzyme α-galactosidase A
- Also known as angiokeratoma corporis diffusum, ceramide trihexosidosis, α-galactosidase A deficiency, or Anderson-Fabry disease
- Multisystem, progressive disease that can have cutaneous, cardiovascular, cerebrovascular, renal, neurologic, and psychiatric manifestations
- Second most prevalent lysosomal storage disease (after Gaucher disease)
- Manifests primarily in men (given that it is X-linked), but female heterozygotes are also affected
- Reported incidence from 1:3,100 to 1:117,000 live male births, although the prevalence is likely underestimated given delays in diagnosis (1). Female prevalence is unclear due to underdiagnosis.
- Underdiagnosed due to rarity of Fabry disease, which is often not considered by clinicians
- Diagnosis may be missed in young patients with stroke or hypertrophic cardiomyopathy of unknown cause.
Can present in male children around 6 to 8 years and females around 9 years (1), although median age at diagnosis is often later in patients without a known family history. Children often present initially with neurologic or gastrointestinal symptoms (2). The mean age of onset of neurologic symptoms in males is 10 years.
Etiology and Pathophysiology
- X-linked inborn error of the glycosphingolipid metabolic pathway
- Deficiency of α-galactosidase A results in the accumulation of globotriaosylceramide (Gb3) in lysosomes in multiple cell types throughout the body.
- Accumulation of Gb3 is particularly prominent in the vascular endothelium and smooth muscle cells, leading to vascular occlusion, ischemia, and infarct.
- GLA gene located on the long arm of the X chromosome, Xq22
- X-linked inheritance pattern
- OMIM #301500
- Men are more commonly affected because they are hemizygous for this (X-linked) gene. Up to 70% of heterozygous females have mild to pronounced features.
- Genetic testing is available. If family history suggests a diagnosis of Fabry disease, genetic testing and counseling should be offered to all family members, regardless of gender.
Fabry disease is a hereditary disorder. Early identification and proper management can prevent or delay complications.